AS Genomic Analysis has entered into an agreement with Microbiome Research Pvt. Ltd. to launch GA-map technology in India

Oslo, Norway – 16 January 2023: Molecular Diagnostic Specialist, AS genetic analysis (“GA”) has entered into a Technology Transfer Agreement with Microbiome Research Pvt. Ltd. (“MRPL”)And a Mumbai Biotechnology company providing microbiome classification services within the gut microbiome space India. MRPL will launch a testing service suite based on the GA-map® Dysbiosis Test – making it the first CE-IVD-labeled standardized gut microbiome test in the Indian market. The service offering will also target clinical research clients and medical clients. Commercial launch is expected in Second quarter 2023.

Ronnie HermansenExecutive Director of Genetic Analysis, comments:
“GA continues to enter new markets, and we are proud to have MRPL as a partner in such an emerging market India. GA map® The platform offers a rapid lab testing service with an integrated software algorithm to display immediate results of your microbiome analysis. We believe that microbiome testing will soon be a game-changer in medicine, and we are certain that the GA-map® platform will be of great support to MRPL in its mission to help people in India Understanding their microbiome.

market demand in India Assessments of the gut microbiome are rapidly increasing in private healthcare services, medical clinics, and academic research, with dysbacteriosis being a new and emerging concept. Together with the MRPL, GA can now offer the CE-IVD-branded standardized gut microbiome test to the Indian market to meet the growing interest and increased awareness of dysbacteriosis. While the immediate market potential for GA-map® is difficult to determine, the second best way to understand the market potential is to look at Digestive health The market and the probiotics market. Research shows that around 50% of Indian families report digestive health issues with indigestion, acidity and gas being the top 3 digestive health issues. This indicates a huge potential for GA-map® testing. Another indicator of market potential is the probiotics market that is currently being evaluated 35 million US dollars And it’s growing at a 40% compound annual growth rate. Together, these two indicators provide insight into the potential of GA-map®.

Ravi ShroffFounder and Managing Director, MRPL, comments:
“Our mission is that we want to get to the root of the problem that arises from the gut. The vision is how we can get people to take charge of their own health. By offering different gut microbiome profiling services, we are an early mover in this space with a coordinated India. We’re building an entire ecosystem around gut health and genetic testing. Launching services based on a CE-marked clinical microbiome test powered by GA-map® technology is a significant milestone in our journey to develop this market. “

For more information, please contact:Ronnie Hermansenchief executive officer

About Microbiome Research Pvt. Ltd.:
Founded in 2016, Microbiome Research Pvt. Ltd (MRPL) is MumbaiIt is the only microbiome company in the country with an in-house laboratory leading some of the cutting-edge research in the microbiome field. MRPL offers a wide range of laboratory and R&D services in the UK India.

For more information:

About AS genetic analysis:
AS genetic analysis (GA) is a science-based diagnostics company and leader in the human microbiome field with over 10 years of experience in research and product development. The unique GA-map® platform is based on a predefined multiplex targets approach specialized for the simultaneous analysis of a large number of bacteria in a single reaction. Test results are generated through the use of a sophisticated, clinically validated GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading manufacturer of standardized tests for the gut microbiome worldwide, and GA is committed to helping unlock and restore the human microbiome through its state-of-the-art technology. GA employs a team of highly qualified personnel with scientific backgrounds and proficiency in Bioinformatics, Molecular Biology and Bioengineering.

Interested in reading more about GA products? Please visit–ltd–to-launch-ga-map- -Technology, c3697517

(C) 2023 Cision. all rights are save. , Source Press releases – English

Leave a Comment